Member Info for VertizeaSun

Will it be on the BBC? As far as I can see Avacta has given up trying to deal with the UK regulator. DEI anyone?

I watched the video and CC seemed fine to me - probably bored with explaining preCISION to dumb and dumber..... for further information read

Wynbores essays.

I asked Al how penicillin was received at the outset:

"Penicıllin faced skepticism and criticism when it was first announced, particularly regarding its effectiveness and the methods used in its discovery. Many in the medical community were doubtful about its potential, as evidenced by the initial reception of Alexander Fleming s findings in 1929."

It took another 14 years for it to become widely accepted....in Australia and the US. The British Pharma industry initially refused to develop it.

So Avacta's five years and counting isn't too bad, compared to the usual ten years from drawing board to the arms of run of the mill patients

"Comments on here don't usually shock me "

You should get out more.

An RNS with either £ or $ + digits will be here shortly. Avacta's cash runs out (probably) in January and CFO's will always want at least six months in hand so a top-up is due any day now. Before the AGM on the 22nd is my guess.

An NDN/Eggy/Thornogson classic:

"Mission drift.

They’re playing a weak hand as best they can."

To be archived. !st June 2026.

Relax.....a few day traders ****** around. That's all.

111 patients multiple dosed and not a single failure. An outstanding invention.

“Dog excrement”……harsh but fair.

"The real catalyst to watch now isn't a conference presentation, but rather the upcoming initiation of their Phase II pivotal trials and potential partnering discussions."

You've lost me.

Isn't Avacta identifying a partner prior to Phase II? And presenting data before even that?

He was probably referring to his fave Chablis.

The last day of the conference!

Because he acknowledged and confirmed the authenticity of ""Richard Hughes@hughesy0707"

months ago.

Https://www.peptideandprotein.com/item/application%2F2026-05-26_oncology-peptides-future-outlook-macrocycles-radioligands-conjugates-vaccines.html?tags

"The Oncology Peptide Inflection: Macrocycles, Radioligands, Conjugates, and Vaccines, and Where They Go Next"

Except CC told us that had so much new data they'd release it in two tranches.....firstly at ASCO and then ESMO at the end of June.

If you actually read posts you'd know there is a glitch in the LSE uploading process and it auto delete's posts. They'll be back in a couple of hours......unfortunately.

That's a bit rude.....describing Derek like that.

Yes....more or less.

And this means results from patients beginning their treatment on 11th August 2021. How time flies ....

Why don't you ask a doctor who's actually using AVA6000?

"It is like having a rocket with a nuclear bomb inside, and the rocket is directed right away to the cancer cells – not to the body, because it would destroy the body, but to the cancer cells – and therefore able to spare the other parts of the body. Avacta has an incredible technology, because the drug that they that are using called Doxorubicin is an incredible drug. It was one of the first chemotherapies, but the limitation of this medication was heart toxicity, so you had a strong limitation in giving Doxorubicin because of increasing the risk of heart attacks. Now you can improve the dose, because the drug will concentrate only in the tumor environment. This is very, very important."

https://www.alainelkanninterviews.com/virgilio-sacchini-4/

The idea was tried with antibiotics in unregulated agriculture.